VCRC Longitudinal Study of Relapsing Polychondritis (RP)

The data from this study will be used by scientists to study the causes of RP, understand better what patients feel with RP, find new ways to track symptoms and predict responses, and to understand how to best treat patients with RP. There are no study drugs involved with this study. Study visits are combined with regular clinic visits to your rheumatologist at Penn.

ClinicalTrials.gov ID: Not applicable

Study Duration: Up to 6 years

Disease(s): Relapsing Polychondritis (RP)